Potential Mutagenic Impurity (GTI) Assessments
Using a range of different software tools, Arcinova has the necessary expertise to assess the mutagenic potential of impurities and degradation products from drug substance and drug product manufacture, which is required for successful regulatory submissions and to comply with ICH M7 guidance,
Some impurities, which are highly reactive because of their structure, have the potential to interact with DNA.
Bio2Business 2018Bio2Business Basel 2018 will be attended by Nathalie Huther, Business Development Manager Europe.
Bio2Business 2018Dates: 19th - 20th JuneLocation: Basel, Switzerland
ChemSpec EuropeThe ChemSpec Europe Conference will be attended by Gareth Jenkins, Chief Scientific Officer at Arcinova. Gareth has been invited to chair 'Sessions 3 and 5' for the Royal Society of Chemistry's Special Symposium, during the two-day event.
ChemSpec EuropeDates: 20th - 21st June 2018Location: Cologne, Germany
Scale-up of Chemical Processes ConferenceThe Scale-up of Chemical Processes Conference will be attended by Nathalie Huther, Business Development Manager Europe.
Scale-up of Chemical Processes ConferenceDates: 25th - 27th JuneLocation: Prague